People: Actelion Ltd (ATLN.VX)

ATLN.VX on Virt-X Level 1

85.85CHF
17 Apr 2014
Price Change (% chg)

CHF0.15 (+0.18%)
Prev Close
CHF85.70
Open
CHF87.40
Day's High
CHF87.95
Day's Low
CHF85.50
Volume
933,073
Avg. Vol
602,696
52-wk High
CHF93.45
52-wk Low
CHF52.45

Search Stocks

Kessler, Armin 

Brief Biography

Mr. Armin M. Kessler has been Member of the Board of Directors of Actelion Ltd since 2004. He is Chairman of the Compensation Committee and Member of the Nominating and Governance Committee of the Company. He served as Chief Operating Officer of F. Hoffmann-La Roche Ltd from 1990 till 1995. Prior to that appointment, he held senior management positions at Roche, including Head of Diagnostics and Pharmaceutical divisions. Earlier positions included Director of Pharmaceutical Marketing Worldwide at Sandoz (now Novartis) and President of Sandoz KK in Tokyo. He served also on the Board of Syntex Chemicals, Genentech and F. Hoffmann-La Roche. He is also Vice Chairman of the Board of Directors and Lead Director of Gen-Probe Inc. He is Member of the Board of Directors of The Medicines Co. and MedGenesis Therapeutix Inc, as well as Vice Chairman and Lead Director of Gen-Probe Inc. He holds a degree in Physics and Chemistry from Pretoria University in South Africa, degree in Chemical Engineering from the University of Cape Town and Juris Doctor title from Seton Hall University. He is registered Patent Attorney at the United States Patent Office.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
223,114 -- -- 223,114

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks